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ABSTRACT
Introduction: The prevalence of hypertension
has continued to increase and is now a great
burden for health care providers. Obtaining
information on the factors affecting
compliance to antihypertensive drugs is thus
important. The aim of this study was to assess
knowledge of hypertension and to determine
factors affecting the compliance of hypertensive
patients to their antihypertensive drugs.
Methods: This was a cross-sectional study
involving 221 hypertensive patients in the
Bamenda Health District. Validated
questionnaires were used. From December
2014 to March 2015, knowledge of
hypertension was assessed using a 15-item
scale, while compliance was assessed using the
8-item Morisky Medication Adherence Scale.
Statistical analysis was performed using SPSS
version 20.
Results: 14.0%, 53.4%, and 32.6% of
participants had adequate, average, and poor
knowledge of hypertension, respectively. The
antihypertensive compliance rate was 43.9%.
Independent predictors of noncompliance were
forgetfulness (OR = 0.011, 95%
CI = 0.002–0.063), lack of motivation due to
the incurable nature of the disease (OR = 0.068,
95% CI = 0.017–0.274), and lack of symptoms
of the disease (OR = 0.019, 95%
CI = 0.02–0.23). There was a significant
association between compliance and blood
pressure control (p\0.001).
Conclusion: Knowledge of hypertension was
poor. Compliance rate to treatment was low.
Some medication-related, patient attitude, and
health care provider factors affected
Enhanced content To view enhanced content for this
article go to www.medengine.com/Redeem/
EC47F0601CC1A059.
B. M. Akoko  P. N. Fon
Faculty of Health Sciences, University of Buea, Buea,
Cameroon
B. M. Akoko  R. C. Ngu
Human Health and Disease Connection (2HD)
Research Group, Douala, Cameroon
R. C. Ngu (&)
Mboppi Baptist Hospital Douala, Douala, Cameroon
e-mail: rolinaro@gmail.com
R. C. Ngu
Medical Doctors (MD) Research Group, Douala,
Cameroon
K. B. Ngu
Faculty of Medicine and Biomedical Sciences,
University of Yaounde I, Yaounde, Cameroon
Cardiol Ther
DOI 10.1007/s40119-016-0079-x
compliance. Knowledge positively affected
compliance, and good compliance was
associated with good blood pressure control.
Emphasis should be placed on patient
education and reminders to patients to take
their drugs.
Keywords: Antihypertensive drugs; Compliance;
Hypertension; Knowledge
INTRODUCTION
Hypertension is a chronic disease characterized
by elevation of blood pressure. Medication
compliance refers to the act of conforming to
the recommendations made by the provider
with respect to the timing, dosage, and
frequency of medication taking. It is measured
over a period of time [1].
In 2008, 40% of adults worldwide aged 25
and above had been diagnosed with
hypertension, and the number of people living
with hypertension stood at 1 billion [2].
Hypertension is a major health problem in
Cameroon. In 2003, in a study of a population
of 10,011, the prevalence was reported as 24.6%
[3]: 25.6% in males and 23.1% in females.
Previously considered a disease of the
developed world, hypertension is occurring
with increasing frequency in developing
countries. This increasing prevalence of
hypertension has been attributed to increased
urbanization and westernization of lifestyles,
with a higher prevalence found in the urban as
opposed to rural areas [4]. In addition, the
prevalence of hypertension is expected to
continue to increase globally [5]. The number
of adults with hypertension in 2025 is predicted
to increase by about 60%, to a total of 1.56
billion.
The prevalence of hypertension is also
increasing in Cameroon, as seen from a study
assessing changes in blood pressure values over
a 10-year period between 1994 and 2003 [6].
The study revealed an increase in mean blood
pressures in rural women (SBP ?18.2 mmHg,
DBP ?11.9 mmHg) and men (SBP ?18.8 mmHg,
DBP ?11.6 mmHg). In the urban areas, SBP
increased in women (?8.1 mmHg, p\0.001)
and men (?6.5 mmHg, p\0.001), while DBP
increased only in women (?3.3 mmHg,
p\0.001). There was also a significant (two- to
fivefold) increase in the prevalence of
hypertension (crude and age-adjusted) in rural
and urban men and women over the ten-year
period. All of these data indicate that
hypertension is currently a big challenge to
health workers and will continue to be for some
time to come.
Blood pressure control involves the
implementation of a number of lifestyle
modifications as well as the use of one or
more antihypertensive drugs [7]. Lifestyle
modifications include (amongst others)
adjustment of the diet, cessation of smoking,
reduction of alcohol intake, weight reduction or
control, increase in physical exercise, and stress
management. Although lifestyle modifications
are important, patients may also require one or
more antihypertensive drug(s) to achieve
effective blood pressure control. These drugs
will have to be taken by the patient throughout
his/her life [7].
The most common complications of
hypertension include stroke (cerebrovascular
accident), ischemic heart disease, retinopathy,
nephropathy, and peripheral vascular disease
[8], which can be prevented or delayed by
effective blood pressure control. In a study in
Douala (2014), hypertension was found to be
the most common risk factor for stroke in
patients in Cameroon, with 81.2% of stroke
victims found to have a positive history of
hypertension [9].
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While educating patients is the
responsibility of qualified health personnel,
compliance to therapy depends on the
individual patient. A study carried out in Buea
(Cameroon) in 2014 revealed that only 33.3% of
hypertensive patients were complying with
their antihypertensive drug therapy [10]. In a
resource-poor setting in Nigeria, only 32.1% of
the hypertensive patients showed good
compliance [11], whereas in a resource-poor
setting in Pakistan, it was 48.3% [12]. A study
performed in 2012 in Cameroon revealed that
only 59.9% of known hypertensive patients
were taking antihypertensive drugs, despite
being aware of their condition [13]. The
reasons for this poor compliance need to be
better understood if they are to be modified.
We undertook this study to assess patient
knowledge of hypertension in hypertensive
patients as well as to determine factors
affecting the compliance of these patients with
their medication, as this information could help
to guide the development of interventions to
improve drug adherence facilitating
optimization of blood pressure control among
patients with hypertension in Cameroon.
METHODS
Study design and setting
This was an observational cross-sectional study
carried out in the Bamenda Health District of
the North West Region of Cameroon over a
period of four months (December 2014 to
March 2015). This health district has a
population of about 336,372 persons
according to the 2012 national census. It is
one of the 19 health districts of the North West
Region and comprises 17 health areas: Nkwen
Baptist, Nkwen Urban, Mbatchangwa,
Atuakom, Ntambag, Ntamulung, Mulang,
Azire, Alakuma, Bamendakwe, Ndza,
Akumlam, Alabukam, Mankon, Alamandum,
Nkwen Rural, and Ntankah.
Study Participants and Data Collection
The sample population comprised hypertensive
patients who were aged at least 21 years at
diagnosis, were on antihypertensive
medications for at least 6 months, and resided
in communities in the various health areas in
the Bamenda Health District of Cameroon. We
excluded hypertensive patients who were not
on pharmacologic treatment.
Sensitization of the patients was achieved
by making announcements in community
group meetings and churches. This made
them aware of the study beforehand so as to
reduce resistance and hostility towards the
interviewer.
A convenient sampling method was used.
Health areas in this study were chosen based on
ease of access and familiarity to the interviewer.
The minimum sample size was calculated
using the formula s = z2[p(1 - p)]/d, where
s = minimum sample size, z = standard normal
variate, p = an estimate of the proportion of the
patients in the study who complied with their
antihypertensive drug regimens, d = sample
error to be tolerated, and the confidence
interval = 5%. Therefore d = 0.05, confidence
level = 95%. This implies z–score = 1.96.
Predicted proportion of the patients who
complied with their antihypertensive drug
regimens (p) = 13% (this was the compliance
in a similar study in Bangladesh [14]).
A minimum sample size of 174 patients was
required, but 221 hypertensive patients were
ultimately recruited. Hypertensive patients in
various health areas in the Bamenda Health
District were then approached so as to include
them in the study.
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Structured and validated questionnaires were
administered orally by the investigator to
persons who consented. The questionnaires
were used to obtain information on the
sociodemographic status of the participants, to
assess knowledge of hypertension, to assess
compliance with antihypertensive therapy, and
to determine the factors affecting compliance.
Blood pressure was measured twice on the
same arm after the participant had rested for
5 min, and the average of both values was
considered the blood pressure of the participant.
After data collection, participants were
educated on the basics of hypertension and its
management, and the correct answers to the
section on knowledge were given to the
participants. Emphasis was placed on the
importance of good antihypertensive drug
compliance. Any questions the participants




The data were collected as stated above and
entered into Microsoft Excel 2013. SPSS version
20 was used to analyze the data.
Knowledge of hypertension was assessed on a
scale of 15, based on answers to 15 questions, as
shown below (Table 1). The scale was adapted
from one used in a similar study in Pakistan to
assess knowledge of hypertension [15]. A score of
less than 8 represented poor knowledge, a score
of 9–12 represented average knowledge, and a
score of 13–15 represented adequate knowledge.
To assess the association between knowledge
and compliance, participants were grouped into
those who had adequate knowledge and those
who had inadequate knowledge. Compliance
with antihypertensive medication was
measured using the 8-item Morisky
Medication Adherence Scale. Compliance was
measured on a scale of 8 based on answers to 8
questions. A score of less than 3 represented
compliance and a score of 3–8 represented
noncompliance.
Blood pressure control was assessed as
recommended by Joint National Committee
JNC 8 [16], based on the blood pressure
reading obtained. Blood pressure \140/
90 mmHg represented good blood pressure
control in patients less than 60 years old, blood
pressure C140/90 mmHg represented poor
blood pressure control in patients less than
60 years old, blood pressure \150/90 mmHg
represented good blood pressure control in
patients aged 60 years and above, and blood
pressure C150/90 mmHg represented poor
pressure control in patients 60 years and above.
Other questions in the questionnaire were used
to collect information on sociodemographic
factors, medication-related factors,
complications, and health care provider factors.
All variables were categorized. Chi-square and
Fisher’s exact tests were used as tests of statistical
significance to examine the relationships
between variables. Variables were divided into
sociodemographic, medication-related, and
health care provider-related factors, and
analyzed with compliance as the dependent
variable. This was used to determine how these
factors affected patient compliance. Multivariate
analysis of factors which had a statistically
significant association with compliance was
done by logistic regression to identify
independent predictors of noncompliance.
Statistical significance was established at
p\0.05.
Compliance with Ethics Guidelines
All procedures followed were in accordance
with the ethical standards of the responsible
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committee on human experimentation
(institutional and national) and with the
Helsinki Declaration of 1964, as revised in
2013. They were also in accordance with the
ethical standards of the Institutional Review
Board of the Faculty of Health Sciences,
University of Buea, Cameroon.
Informed consent was obtained from all





Of the persons approached during data
collection, 221 met the inclusion criteria for
the study. Of the 221 participants, 98 (44.3%)
were male. Ages of participants ranged from 37
to 86 years, with a mean age of
62.86 ± 11.4 years. 147 (66.5%) reported that
they were married, and 96 (43.3%) were retired.
65 (29.4%) had received secondary education,
as opposed to 64 (29%) who had received no
formal education (Table 2).
Knowledge of Hypertension
Of the 221 participants in this study, 31 (14.1%)
had adequate knowledge of hypertension. 118
(53.4%) had average knowledge, while 72
(32.6%) had poor knowledge of hypertension.
The factors which positively affected knowledge
of hypertension significantly were male sex, age
less than 63 years, and higher level of education
(Table 3).
Table 1 Knowledge of hypertension questionnaire
Question Yes No Don’t know
1 Do you know the value above which blood pressure is described as high?
2 Elevated blood pressure is called hypertension
3 A patient always has symptoms like headache, dizziness and fatigue
each time his/her blood pressure is high
4 Both men and women have equal chances of developing hypertension
5 Hypertension is a curable condition
6 The older the person is, the greater their chances of having hypertension
7 Smoking increases the chances of developing hypertension
8 Eating fatty foods increases the chances of developing hypertension
9 Being overweight increases the chances of developing hypertension
10 Regular physical activity reduces a person’s chances of developing hypertension
11 Eating more salt has no effect on blood pressure
12 Dietary approaches to reduce hypertension do no good
13 Red meat is good for control of hypertension
14 Medication alone can control hypertension




Of the 221 participants in this study, 97 (43.9%)
persons were found to be compliant with their
antihypertensive drug treatments, while 124
(56.1%) persons were found to be
noncompliant. Some medication-related
factors, patient factors, and health care
provider-related factors were found to have
statistically significant associations with
compliance. These are shown in Table 4. The
independent predictors of noncompliance
following logistic regression were forgetfulness,
lack of motivation due to the incurable nature




Of the 31 participants who had adequate
knowledge of hypertension, 23 (74.2%) were
compliant while 8 (25.8%) were noncompliant.
Of the 190 participants who did not have
adequate knowledge of hypertension, 74
(38.9%) were compliant while 116 (61.1%)
were noncompliant. This association between
compliance and knowledge on hypertension
was statistically significant (p\0.001).
Blood Pressure Control
The systolic blood pressure (SBP) of the
participants in this study ranged from 103 to
223 mmHg, with a mean of 154.29 ±
26.8 mmHg. The DBP of the participants
ranged from 57 to 160 mmHg, with a mean of
90.07 ± 15.98.
Ninety-three participants (42.1%) had good
BP control, while 128 (57.9%) had poor BP
control. The factors associated with good BP
control are shown in Table 6.
DISCUSSION
We found that 31 participants (14.0%) had a
knowledge of hypertension which could be
considered adequate. 118 participants (53.4%)
had average knowledge and 72 (32.6%) had
poor knowledge of hypertension. This was
Table 2 Sociodemographic characteristics of the






























similar to knowledge levels observed in Quetta,
Pakistan, in which 37.9% of participants had
poor knowledge, 61.3% had average knowledge,
and only 0.8% had adequate knowledge of
hypertension [15]. In Ido-Ekiti, Nigeria, less
than half of participants (47.1%) had good
knowledge of hypertension [11]. These were
however lower than values obtained in North
Carolina, where 78% of participants had a good
knowledge of hypertension [17].
The compliance rate among participants in
our study was 43.9%, indicating that slightly
less than half of the participants were compliant
with their antihypertensive medications. This
rate is similar to those observed in studies in
Shiraz, Iran (39.6%) [18], Malaysia (44.2%) [19],
Maringa, Brazil (46%) [20], and Abbottabad,
Pakistan (48.3%) [12]. These countries with
similar compliance rates are all developing
countries. Health care systems are not the best
in these countries, and when coupled with
patient factors or the patients’ attitude
towards health, adherence rates are likely to be
low. The compliance rate seen in the present
work was lower than the corresponding rates
observed in Ethiopia (64.6%) [21] and Idikan
(51%) [22]. It was also lower than the range of
rates, 50–70%, obtained by WHO from a review
of various studies in different countries [23].
The compliance rate in our study was higher
than the 33.3% compliance rate obtained in
Buea [10] and the 32.1% compliance rate
obtained in Ido-Ekiti [11].
Females were slightly more compliant than
males. This difference was not statistically
significant. A similar result was noted in
studies in Maiduguri [24] and the DR Congo
[25], in which no statistically significant
Table 3 Factors affecting knowledge of hypertension
Variables Frequency (percentage) P value
Poor Average Adequate
Gender
Male 24 (24.5%) 58 (59.2%) 16 (16.3%) 0.036*
Female 48 (39.0%) 60 (48.8%) 15 (12.2%)
Age (years)
\63 12 (11.0%) 78 (71.6%) 19 (17.4%) <0.001*
C63 60 (53.6%) 40 (35.7%) 12 (10.7%)
Educational status
No formal education 52 (81.2%) 12 (18.8%) 0 (0.0%) <0.001*
Primary 10(25.0%) 30 (75.0%) 0 (0.0%)
Secondary 8 (12.3%) 48 (73.8%) 9 (13.9%)
Tertiary 2 (3.9%) 28 (53.8%) 22 (42.3%)
Clinic attendance
Keep clinic appointments 36 (30.3%) 60 (50.4%) 23 (19.3%) 0.063
Do not keep clinic appointments 36 (30.3%) 58 (56.9%) 8 (7.8%)
* Statistically signiﬁcant
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Male 38 38.8 0.808 (0.593–1.102) 0.171
Female 59 48.0
Age (years)
Less than 63 45 41.3 0.889 (0.659–1.200) 0.441
63 and above 52 46.4
Marital status
Married 61 41.5 0.853 (0.630–1.155) 0.312
Widowed/single 36 48.6
Educational status
No formal education 28 43.8 0.995 (0.716–1.384) 0.067
At least primary 69 43.9
Employment status




One drug 35 41.2 0.903 (0.660–1.236) 0.520
More than one 62 45.6
Belief in drug efﬁcacy
Yes 95 47.7 0.190 (0.050–0.720) 0.001*
No 2 9.1
Cost of medications
Affordable 69 59.0 2.190 (1.542–3.111) <0.001*
Expensive 28 26.9
Drug availability
Readily available 97 46.4 – 0.002*
Not readily available 0 0.0
Side effects
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association between gender and compliance
was observed. However, in Dar es Salaam,
there was a statistically significant difference,
with females found to be more compliant than
males [26]. Contrarily, in Taiwan, males were
significantly more compliant than females [27].
There was no significant association between
age and compliance. This was similar to results
of studies done in Ethiopia [21] and Lusaka [28],
where there was also no significant association.
This was, however, contrary to findings in the
DR Congo [25] and Shiraz, Iran [18], in which
there was a statistically significant association,
with older participants being more compliant
than younger ones.
We found no significant association between
compliance and marital status. Similar results
were obtained in Dar es Salaam [26] and Shiraz,
Iran [18]. This result was, however, contrary to
findings in Maiduguri [24], in which married
participants were found to be significantly more
compliant than single participants.
Educational status had no significant
association with compliance. This was similar
















Yes 81 68.1 0.230 (0.145–0.367) <0.001*
No 16 15.7
Forgetfulness
Never forget 79 90.8 6.760 (4.375–10.444) <0.001*
Sometimes forget 18 13.4
Use of traditional medicine
Yes 8 13.8 3.959 (2.049–7.647) <0.001*
No 89 54.6
Lack of motivation due to incurable nature of disease
Yes 14 13.2 5.465 (3.311–9.019) <0.001*
No 83 72.2
Stop medications when feeling well




There was no significant association between
compliance and occupational status.
Participants in active employment were not
more or less compliant than those who were
not. This was similar to findings in Taiwan [27]
and DR Congo [25].
There was no significant association between
the number of antihypertensive drugs the
participant was taking and compliance with
treatment. This was similar to findings in
Taiwan [27]. A controlled trial done on
hypertensive patients in Japan also supported
this [29]. This was contrary to findings in Buea
[10], where participants on a single drug were
significantly more compliant than those on
multiple drugs. The reverse was true in
Maiduguri [24] and Lusaka [28], where
participants on more than one drug were
significantly more compliant.
Participants who believed in the efficacy of
the drugs they were taking were more
compliant than those who did not believe in
the efficacy of the drugs. This difference was
statistically significant. This was in accordance
with findings in Shiraz, Iran [18].
Participants who found the drugs to be
affordable were more compliant than those
who found the drugs expensive. This
difference was statistically significant. This was
similar to findings in Maiduguri [24], the DR
Congo [25], and India [30].
The participants who reported that their
drugs were not readily available were
significantly less compliant. This was similar
to findings in Ido-Ekiti [11] and Kuwait [31].
Patients who could not get the drugs they had
been prescribed were less likely to be compliant
because, even if they had the will, they did not
Table 5 Independent predictors of good compliance to antihypertensive medication
Factor Adjusted odds ratio 95% Conﬁdence interval p value
Knowledge of hypertension 0.694 0.113–4.252 0.693
Medication-related factors
Belief in drug efﬁcacy 5.497 0.240–126.045 0.286
Medication cost 0.745 0.174–3.187 0.692
Drug availability – – 0.998
Side effects 0.321 0.039–2.632 0.290
Patient attitude/factors
Forgetfulness 0.011 0.002–0.063 <0.001*
Clinic attendance 2.842 0.611–13.216 0.183
Traditional medicine 1.376 0.185–10.226 0.755
Lack of motivation due to incurable nature of disease 0.068 0.017–0.274 <0.001*
Asymptomatic nature of disease 0.019 0.02–0.231 0.020*
Health care provider factor
Condition explanation 3.221 0.574–18.089 0.184
* Statistically signiﬁcant
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have the drugs, preventing them from taking
their medications as prescribed.
Participants who reported side effects of their
drugs were significantly less compliant than
those who had never experienced any side
effects. This was similar to findings in Lusaka
[28] and Idikan [22]. People who experience
unwanted effects after taking a drug are more
likely to stop taking the drug, resulting in poor
compliance.
Some participants never forgot to take their
medications. Others sometimes forgot and were
less compliant. This difference was statistically
significant. Similar findings were obtained in
Idikan [22] and Kuwait [31].
There was a statistically significant difference
in compliance between participants who
regularly kept clinic appointments and those
who did not keep appointments. Those who
kept clinic appointments were more compliant.
This was similar to findings in Lusaka [28] and
Mahe in the Seychelles [32].
There was a statistically significant difference
in compliance between participants who used
traditional medicine to treat their hypertension
and those who did not. Those who did not use
traditional medicine were more compliant.
Similar findings were obtained in Ido-Ekiti [11]
and Dar es Salaam [26]. People who tend to use
traditional medicine generally believe that the
traditional treatment is just as, if not more,
effective than the medical treatment. There is
therefore competition between the two
treatment options, leading to reduced
compliance with medical treatment.
Participants who reported a lack of
motivation to take their drugs due to the
incurable nature of hypertension were less
Table 6 Factors associated with good blood pressure control
Variables Frequency Percentage Odds ratio (95% CI) P value
Gender
Male 34 34.7 0.723 (0.521–1.004) 0.047*
Female 59 48.0
Age (years)
Less than 63 37 33.9 0.679 (0.493–0.936) 0.016*
63 and above 56 50.0
Alcohol consumption
Yes 44 31.9 1.852 (1.368–2.506) <0.001*
No 49 59.0
Smoking
Yes 0 0.0 – 0.014*
No 93 43.7
Compliance




compliant than those who had no motivational
problems. This association was statistically
significant. This was similar to findings in
Idikan [22] and Dar es Salaam [26].
Participants who stopped taking their drugs
because they felt better or had no symptoms
were less compliant than those who did not
stop. This association was statistically
significant. This is similar to findings in
Maiduguri [24] and India [30]. Hypertension
usually does not present with any symptoms.
Therefore patients who rely on symptoms to
take their medications are likely to be
noncompliant, as they will certainly skip
several doses of treatment when they feel well.
The gravity of this is also seen in another study
done in Nigeria, where as many as 58.3% of the
participants believed that antihypertensive
drugs should only be used when there are
symptoms [33].
There was no significant association between
compliance and complications. Participants
who had experienced at least one
complication of hypertension were not more
or less likely to be compliant than those who
had never experienced a complication. This is
similar to what was obtained in Buea [10]. Our
findings were contrary to findings in the DR
Congo [25] and Shiraz, Iran [18], where patients
who had experienced at least one complication
were more likely to be compliant than those
who had never experienced any complication.
Among the participants who regularly kept
clinic appointments, there was no statistically
significant association between compliance and
confidence in the attending health care
personnel.
Participants who were satisfied with how
much health care personnel told them about
hypertension were more compliant than those
who felt they were not told enough about the
disease. This relationship was statistically
significant. This is similar to what was
observed in Lusaka [28]. Patients who are
satisfied with what they are told with respect
to management will feel more involved in the
management process and will be more likely to
play their role, which is compliance with the
treatment.
There was a statistically significant
association between knowledge of
hypertension and compliance with treatment.
Participants who had adequate knowledge of
hypertension were more compliant than those
who did not. This was similar to findings in
Ido-Ekiti [11] and India [30]. Patients who have
more knowledge of hypertension as a whole will
have better understanding of the disease. They
will therefore better understand important
aspects of the disease such as its asymptomatic
nature and the need for long-term treatment.
They are therefore more likely to be compliant.
This was, however, contrary to what was found
in Quetta, Pakistan (Quetta, Pakistan), where
there was an inverse relationship between
knowledge and compliance [15].
42.1% of participants had controlled BP. This
was similar to the BP control rate of 36.6%
obtained in Ethiopia. This was higher than the
BP control rates of 21.3% obtained in Buea [10]
and 29.4% obtained in the DR Congo [25]. It
was also higher than the BP control rate of
24.5% obtained from a study involving several
major cities in Cameroon [13]. This is probably
because in those studies with lower BP control
rates, good BP control was considered to be
BP\140/90 mmHg. In our study, this was the
cutoff point only for participants less than
60 years old. In participants aged 60 years and
older, BP control was considered good if BP was
less than 150/90 mmHg. This is in accordance
with the most recent recommendations by JNC
[16]. The higher BP control rates can also be
explained by the fact that our compliance rate
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of 43.9% was higher than the compliance rates
of 33.3% and 21.2% obtained in Buea and the
DR Congo, respectively [10, 25]. All of those
were in line with a systematic review of several
studies done across Africa, which concluded
that the general rate of BP control is low
throughout the continent [34].
There was a statistically significant
association between compliance and BP
control. Patients who were compliant were
more likely to have good BP control than those
who were noncompliant. This was similar to
findings in Buea [10], Kuwait [31], Mahe in the
Seychelles [32], and India [30]. The aim of taking
medications is to achieve a target BP so as to
have good BP control. Good compliance with
treatment will therefore lead to good BP control.
Limitations
Our study had a small sample size of 221
participants. A larger sample size was difficult
to realize due to the fact that we carried out a
community-based study and had the difficult
task of moving around in communities actively
searching for hypertensive patients on
antihypertensive medications. We also used a
self-report method to assess compliance to
treatment, which is an indirect method. While
a self-report method was the most feasible
method to use in our setting, it is not as
accurate as direct methods of assessing
compliance.
CONCLUSION
The knowledge of hypertension among
hypertensive patients in Bamenda Health
District was poor. Less than half of the
patients suffering from hypertension knew
enough about the disease, with only 14% of
participants having adequate knowledge.
The level of compliance with
antihypertensive drugs was poor, with only
43.9% of participants showing good
compliance. There were several reasons for
poor compliance in the Bamenda Health
District: medication-related factors, patient
attitude/factors, and a health care provider
factor. No sociodemographic factor
significantly affected compliance with
treatment. The independent predictors of
noncompliance following logistic regression
were forgetfulness, lack of motivation due to
the incurable nature of the disease, and
asymptomatic nature of the disease.
Knowledge of hypertension positively
affected compliance with antihypertensive
medications. Participants who knew more
about the disease were more compliant.
BP control was poor, with less than half of
the participants (42.1%) having good BP
control. Compliance with treatment positively
affected BP control, as participants who were
compliant with treatment were more likely to
have good BP control.
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